Kaiser Family Foundation Looks AtÂ Views On The U.S. Role In Global Health As a follow-up to a survey conducted in May 2009, this poll examines Americans’ attitudes toward U.S. global health investments and priorities. Some key findings include: the majority of Americans support maintaining (32%) or increasing (34%) spending on…
Wall Street Journal Examines Big Pharma’s ‘Growing Interest’ In Emerging-Market Vaccine Development, Production
The Wall Street Journal examines “big pharma’s growing interest in a corner of healthcare â€“ emerging-market inoculations,” in light of a recent move by Novartis to purchase an 85 percent stake in the Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co.
Polio Eradication Efforts Threatened By Funding Shortfall, Vaccination Resistance In Some Countries, Experts Say
Marking the 10th anniversary since Europe was declared polio-free, the Independent Monitoring Board (IMB) of the Global Polio Eradication Initiative on Wednesday released a report (.pdf) saying there is “a unique window of opportunity to stamp out polio for good,” with the number of reported cases at historical lows, but a funding shortfall of about $1 million is threatening eradication progress, Reuters reports. Polio “remains endemic in three countries — Pakistan, Afghanistan and Nigeria — after India in January became the latest country to become polio-free,” the news agency notes. IMB Chair Liam Donaldson “said the global financial crisis coupled with growing needs for polio funding had led to a shortfall of $945 million out of a total 2012-13 eradication program budget of $2 billion” and that 33 countries would have to cancel their vaccination programs, leaving 94 million children unprotected, according to Reuters (Kelland, 6/20).
“A senior Taliban commander has effectively banned polio eradication in one of the most troubled areas of the Pakistan frontier in an effort to force the U.S. to end drone strikes,” the Guardian reports. “Leaflets distributed in South Waziristan on behalf of Mullah Nazir, the leader of the Federally Administered Tribal Agencies (Fata), accused health workers who administer anti-polio drops of being U.S. spies” and “questioned the sincerity of international efforts to tackle the highly infectious disease,” the newspaper adds.
Reuters examines how the fight against malaria in Africa is helping to fuel the continent’s economic growth. “The number of malaria deaths has fallen dramatically in the last decade due to increased aid spending on basic items such as insecticide-treated bed nets and drugs, the World Health Organization (WHO) says,” the news agency writes, noting that an experimental vaccine from GlaxoSmithKline is showing prospect. The news agency discusses the efforts of AngloGold Ashanti, the world’s third largest gold producer, to prevent and treat malaria among its workers, which “‘made economic sense because of the absenteeism and the cost of medication,’ said Steve Knowles, the head of AngloGold’s anti-malaria operations.”
On Tuesday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, scientists and global health experts focused on malaria eradication, Agence France-Presse reports. “Key among the strategies … is the development of an effective anti-malaria vaccine, a project scientists have been researching since the late 80s. … RTS,S is the most clinically advanced malaria vaccine so far, according to the Malaria Vaccine Initiative,” the news service writes (11/3).
To mark the first World Pneumonia Day, Inter Press Service examines how vaccines and other strategies can be used to combat the disease, which kills more children under age 5 each year “than measles, malaria, and AIDS combined, according to the Global Coalition against Child Pneumonia.”
Subsidized artemisinin-based combination therapies (ACTs) under the Affordable Medicines Facility – malaria (AMFm) program will be available in select countries “in two week’s time,” SABC News reports. The announcement came Monday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya.
A WHO official on Tuesday backed the Afghan government’s decision to declare H1N1 (swine flu) a health emergency, forcing the closure of all schools in the country for three weeks in an effort to contain the virus, IRIN reports. H1N1 has reportedly infected over 300 people, resulting in two deaths.
“The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data,” Reuters reports. “The disappointing results for RTS,S — the world’s first potential malaria vaccine — raise further questions about whether it…